Skip to main content
. 2017 Jun 30;11:142–151. doi: 10.2174/1874285801711010142

Fig. (3).

Fig. (3)

Clinical isolates of S. aureus growing in modified CRA (without sucrose) [A] and modified CRA containing sub-MICs of rifampicin (0.002 or 0.004 µg/mL) [B]. Identification of the isolates: C10, C12, C39, C40 and C50. Biofilm negative: spots with smooth appearance. Biofilm positive: spots with rough appearance.